Working… Menu

Doxycycline for Hereditary Hemorrhagic Telangiectasia (HHT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03397004
Recruitment Status : Active, not recruiting
First Posted : January 11, 2018
Last Update Posted : November 22, 2021
Barrow Neurological Institute
Duke University
Feinstein Institute for Medical Research
University of Pittsburgh
Sunnybrook Health Sciences Centre
Information provided by (Responsible Party):
Unity Health Toronto

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2022